Last reviewed · How we verify
NCT06633796: AMADEO
Pilot Experimental Study: Efficacy of Paraffin Therapy and Occupational Therapy Associated with Robotics in Patients with Erosive Osteoarthritis
NA trial testing AMADEO in Arthrosis in 40 participants. Completed in 15 February 2024.
15 February 2024
Quick facts
| Lead sponsor | IRCCS Sacro Cuore Don Calabria di Negrar |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | treatment |
| Enrollment | 40 |
| Start date | 25 January 2021 |
| Primary completion | 15 February 2024 |
| Estimated completion | 15 February 2024 |
| Sites | 1 location across Italy |
Drugs / interventions tested
- AMADEO
- Standard of care
Conditions studied
- Arthrosis — all drugs for Arthrosis →
Sponsor
IRCCS Sacro Cuore Don Calabria di Negrar — full company profile →
Who can join
Adults 35 to 70, any sex, with Arthrosis. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This is a randomized, evaluator-blinded, non-profit, single-center, exploratory, medical device clinical trial aimed at evaluating the efficacy in terms of reduction of functional limitation of the combination of occupational therapy, paraffin therapy, and robotic arm mobilization compared to the center's SoC, i.e. paraffin therapy and occupational therapy.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT06633796
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of AMADEO
Trials testing the same drug.
- NCT04045080 — Hand Rehab Using AMADEO in PD Patients · NA · unknown
Other recruiting trials for Arthrosis
Currently open trials in the same condition.
- NCT06917235 — Wrist and Carpal Arthrodeses. A 1-year Follow-up Study. · recruiting
- NCT05887284 — Investigation of the Clinical Efficacy of Low-dose Ionizing Radiation in the Treatment of Osteoarthritis · NA · recruiting
- NCT04997005 — The Medacta International AMIStem-P Post-Marketing Surveillance Study · active not recruiting
Other IRCCS Sacro Cuore Don Calabria di Negrar trials
Trials by the same sponsor.
- NCT07487506 — Evaluation and Assessment for Communicable Diseases in Migrants Hosted in Reception Centers · NA · recruiting
- NCT07009613 — Strongyloides Stercoralis Public Health Control in Rwanda · completed
- NCT06308705 — The SsRI/NIE Recombinant Antigen ELISA for the Follow up of Patients Infected by Strongyloides Stercoralis · NA · completed
- NCT05884632 — Daily Adaptive RadioTherapy in Postoperative HypofrActionated Salvage radiothERapy for Prostate Cancer Patients · NA · recruiting
- NCT05682690 — Laparoscopic Eradication of Deep Endometriosis With Nerve-sparing Rectosigmoid Segmental Resection (RSRES_NERVSP) · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06633796 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by IRCCS Sacro Cuore Don Calabria di Negrar
- Last refreshed: 2 December 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06633796.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing